HEPION PHARMACEUTICALS, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
HEPION PHARMACEUTICALS, INC. (HEPA) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$12.28 thousand for the 9-month period ending 2017-03-31, per its 10-Q filed 2017-04-12.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-04-12
- HEPION PHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was $0.00.
- HEPION PHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-06-30 was -$495.60K.
- HEPION PHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-03-31 was $0.00.
- HEPION PHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2015-12-31 was $0.00.
- HEPION PHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$502.21K.
- HEPION PHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$83.27K.
- HEPION PHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$15.85K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 11 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|---|
| 2017-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-04-12 | -$12.28K 10-Q · filed 2017-04-12 | |||
| 2016-12-31 | -$12.28K 10-Q · filed 2017-02-14 | ||||
| 2016-06-30 | -$495.60K derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-28 | -$495.60K derived: sum of 2 quarters · filed 2017-04-12 | -$495.60K derived: sum of 3 quarters · filed 2017-04-12 | -$502.21K 10-K · filed 2016-09-28 | |
| 2016-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-04-12 | $0.00 derived: sum of 2 quarters · filed 2017-04-12 | -$6.60K 10-Q · filed 2017-04-12 | -$6.60K derived: sum of 4 quarters · filed 2017-04-12 | |
| 2015-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-14 | -$6.60K 10-Q · filed 2017-02-14 | -$6.60K derived: sum of 3 quarters · filed 2017-02-14 | -$35.69K derived: sum of 4 quarters · filed 2017-02-14 | |
| 2015-09-30 | -$6.60K 10-Q · filed 2016-11-14 | -$6.60K derived: sum of 2 quarters · filed 2016-11-14 | -$35.69K derived: sum of 3 quarters · filed 2016-11-14 | -$46.08K derived: sum of 4 quarters · filed 2016-11-14 | |
| 2015-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-28 | -$29.09K derived: sum of 2 quarters · filed 2016-09-28 | -$39.47K derived: sum of 3 quarters · filed 2016-09-28 | -$83.27K 10-K · filed 2016-09-28 | |
| 2015-03-31 | -$29.09K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-13 | -$39.47K derived: sum of 2 quarters · filed 2016-05-13 | -$83.27K 10-Q · filed 2016-05-13 | -$83.27K derived: sum of 4 quarters · filed 2016-05-13 | |
| 2014-12-31 | -$10.39K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-12 | -$54.18K 10-Q · filed 2016-02-12 | -$54.18K derived: sum of 3 quarters · filed 2016-02-12 | ||
| 2014-09-30 | -$43.80K 10-Q · filed 2015-11-12 | -$43.80K derived: sum of 2 quarters · filed 2015-11-12 | |||
| 2014-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-25 | -$15.85K 10-K · filed 2015-09-25 | |||
| 2014-03-31 | -$15.85K 10-Q · filed 2015-05-14 | -$15.85K 10-Q · filed 2014-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |